TrialTrials2015

Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.

Xiao-Bing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.